AnalysisNews

KIDS today

$32.58-$1.09 (-3.24%)close Nov 12, 2026

Trend

DailyUptrend (confirmed)

4 hourLeaning Bearish

1 hourStrong Bearish

15 minLeaning Bullish

5 minStrong Bearish

Daily trend turns down below $30.07

Key levels

Resistance$34.53

Resistance$32.62

Support$30.07

Support$28.43

Latest news & SEC filings

ProductOrthoPediatrics launches VerteGlide spinal growth guidance system commercially

ProductOrthoPediatrics starts full commercial release of VerteGlide spine device

AnalystAnalysts Revise OrthoPediatrics Price Targets After Q3 Results

AnalystAnalysts lift price targets on OrthoPediatrics after Q3 results

All KIDS news →

About OrthoPediatrics

OrthoPediatrics is a medical device company focused on children with orthopedic conditions. It creates surgical hardware, tools and custom bracing aimed at young patients, spanning spine curvature, injury repair, limb deformity and joint procedures, and it runs pediatric orthotic and prosthetic clinics. The company serves hospitals, surgeons and caregivers across the United States and many other countries, using direct sales staff, independent agencies and distributors.

Based on the company's 10-K filed Mar 4, 2026.

Nasdaq · Healthcare

ORTHOPEDIATRICS CORP (KIDS)

$32.58-1.09 (-3.24%)
HOLDGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
24.1226.5929.0531.5232.58Oct 12Oct 20Oct 28Nov 5
High34.48
Low32.30
Open33.75
Volume142K
Avg Vol352K
VWAP32.61
30d High33.99
30d Low21.65
30d Chg+47.02%

What Is the Price Target for KIDS?

SEPT Low Target

$24.65

SEPT Mid Target

$29.00

SEPT High Target

$33.35

Analyst Consensus

$29.00

Current: $33.67Upside: -13.9%Confidence: 85%Method: Analyst Consensus

Is KIDS a Buy or Sell Right Now?

46
Investability Score
HOLD12-18 months

Thesis

  • •Revenue growing 15.4% YoY with STRONG trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KIDS.

Start Free Trial →

Is KIDS Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/B, Analyst Consensus

Fair Value

$30.45

41

Moat Score

NARROW

4/9

Piotroski Score

2.0

Altman Z-Score

What Is Smart Money Doing with KIDS?

Insider Signal

SELLING

0 buys / 9 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

DISTRIBUTING

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Pritzker Jennifer N.10% ownerSale302,369$6.4MSep 10, 2026
Squadron Capital LLC10% ownerSale302,369$6.4MSep 10, 2026
Pelizzon David Rdirector 10% ownerSale10,131$234KSep 1, 2026
Squadron Capital LLC10% ownerSale10,131$234KSep 1, 2026
Pritzker Jennifer N.10% ownerSale10,131$234KSep 1, 2026
Pelizzon David Rdirector 10% ownerSale326,700$7.5MAug 28, 2026
Squadron Capital LLC10% ownerSale326,700$7.5MAug 28, 2026
Pritzker Jennifer N.10% ownerSale326,700$7.5MAug 28, 2026
Pelizzon David RdirectorBuy11,436-Jun 9, 2026
Hughes Bryan WdirectorBuy11,436-Jun 9, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

KIDS Growth Story

Revenue YoY

15.4%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-3.05%

FCF Growth YoY

61.4%

Revenue Trend

STRONG

Dark Pool Trades for KIDS

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for KIDS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:00:06$32.581,400$$46KSELL
17:54:12$33.881,667$$56KBUY
15:16:49$33.941,001$$34KMIDPOINT
15:09:25$33.871,876$$64KBUY
14:43:43$34.251,313$$45KBUY

5 dark pool trades shown · $$245K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for ORTHOPEDIATRICS CORP (KIDS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (7 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

KIDS — frequently asked questions

What is KIDS stock price today?

ORTHOPEDIATRICS CORP (KIDS) is at $32.58, down 3.24% (-$1.09) at the Nov 12, 2026 close.

Why is KIDS stock moving today?

Latest KIDS news — Nov 9, 2026: OrthoPediatrics launches VerteGlide spinal growth guidance system commercially · Nov 9, 2026: OrthoPediatrics starts full commercial release of VerteGlide spine device

What is the KIDS price target?

The average analyst price target for KIDS is $29.00, ranging from $27 to $35, based on 6 analysts. Latest: Truist Securities maintains on Oct 28, 2026.

What do analysts rate KIDS?

Analyst ratings for KIDS: 0 Buy, 5 Hold, 0 Sell — consensus Hold.

Did KIDS beat earnings?

KIDS last reported on Oct 27, 2026: EPS -$0.23 vs -$0.21 expected — a miss of 7.3%.

Does KIDS pay a dividend?

KIDS does not currently pay a dividend.

How much debt does KIDS have?

ORTHOPEDIATRICS CORP reported $106M of debt and $17M of cash (Jun 30, 2026).

What are KIDS support and resistance levels?

Support: $30.07, $28.43, $26.74. Resistance: $32.62, $34.53, $36.23.

What are insiders doing with KIDS?

Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.

What is the latest news on KIDS?

Nov 9, 2026: OrthoPediatrics launches VerteGlide spinal growth guidance system commercially · Nov 9, 2026: OrthoPediatrics starts full commercial release of VerteGlide spine device · Oct 29, 2026: Analysts Revise OrthoPediatrics Price Targets After Q3 Results